de Andrés-Nogales F, Ruiz-Moreno JM, Oyagüez I, Casado MA
Extended loading dose of anti-VEGF treatment in diabetic macular edema patients: A cost-consequence analysis
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019
Presa M, Varela C, Oyagüez I
Costs of cytokine release syndrome (CRS) and neurological events (NE) in patients with relapsed/refractory non-hodgkin lymphoma receiving lisocabtagene maraleucel (liso-cel) in the TRANSCEND NHL 001 clinical trial: a micro-costing study from the Spanish National Health System (NHS) perspective
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019
Presa M, Soria A, Oyagüez I, Espinosa E, Echave M, Berrocal A, Manzano JL, Suarez J, Polanco C
Nivolumab-adjuvant therapy for resected stage III-IV melanoma: a cost-effectiveness analysis for Spain
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019
Buti M, Ledesma F, Domínguez-Hernández R, Casado MÁ, Esteban R
Is the universal population hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Rico S, Echave M, Casado MA, Soto J
Systematic review of economic evaluations based on decisión-analytic modeling of cancer drugs
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Peral C, Navarro F, Montoro M, Balsa A, Gomez S, Pablos J, Martinez-Sesmero JM, Valderrama M, Oyagüez I, de Andrés-Nogales F, Casado MÁ
Cost-effectiveness of tofacitinib-containing sequences for rheumatoid arthritis patients in Spain
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Marco A, Domínguez-Hernández R, Casado MA
Clinical and economic impact of the treatment of chronic hepatitis C in prison inmates in Spain
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
de Andrés-Nogales F, Oyagüez I, Morell A, Casado MÁ
Cost analysis of botulinum toxin A (Botox® and Xeomin®) in real-world clinical practice
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
García F, Domínguez-Hernández R, Alados JC, Casado M, Macías J, Téllez F, Pascasio JM, Casado MA